ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641691 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641691; 2) Community: the network communities that were significantly associated with the response to NSC 641691; 3) Molecule: the relationships between components within communities and NSC 641691; 4) MDR: the compounds that were significantly associated with the NSC 641691.

NSC Compound Enrichment Correlation
NSC 732851 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene 0.0219858755288753 0.28155779
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0223138217461954 0.56596995
NSC 630684 8-Quinolinecarboxaldehyde, 2-(2,4-dinitrophenyl)-2-methyl- hydrazone 0.0223138217461955 -0.5433989
NSC 704848 Null 0.0223138217461955 0.041963117
NSC 708240 Cbz-[Lys3]-Didemnin B 0.0223138217461955 0.073069099
NSC 294526 Null 0.0244718705444135 0.26411508
NSC 363812 Tetraplatin 0.0244718705444135 0.48288973
NSC 58239 A 80021F34 0.0244718705444135 0.47284846
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.0244718705444135 0.26403676
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0244718705444135 0.50221743
Total:78  Current:37    [First] [Prev] [Next] [Last]